Back
VNET Group, Inc. Vs. Arrowhead Pharmaceuticals, Inc. Industry Stock Comparison
Buy
64
VNET
VNET Group, Inc.
Last Price:
$9.25
Seasonality Move:
16.68%
Sell
50
ARWR
Arrowhead Pharmaceuticals, Inc.
Last Price:
$70.77
Seasonality Move:
20.18%
Buy
64
VNET Group, Inc. (VNET)
is a Buy
Is VNET Group, Inc. a Buy, Sell or Hold?
-
The current VNET Group, Inc. [VNET] share price is $9.24. The Score for VNET is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
VNET is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Arrowhead Pharmaceuticals, Inc. (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $70.82. The Score for ARWR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VNET Stock Price Chart
What is VNET Group, Inc.'s stock price today?
-
The VNET Group, Inc. share price today is $9.24Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VNET is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals, Inc.'s stock price today?
-
The Arrowhead Pharmaceuticals, Inc. share price today is $70.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing slight buying pressure.
VNET Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.51 | Buy |
| Relative Strength Index (14 RSI): | 52.01 | Buy |
| Chaikin Money Flow: | 1143240 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.56 - 9.44) | Buy |
| Bollinger Bands (100): | (8.06 - 9.96) | Buy |
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.95 | Buy |
| Relative Strength Index (14 RSI): | 77.46 | Buy |
| Chaikin Money Flow: | 740828 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.92 - 62.36) | Buy |
| Bollinger Bands (100): | (20.46 - 47.52) | Buy |
VNET Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.08 | Buy |
| 20-day SMA: | 8.85 | Buy |
| 50-day SMA: | 9.39 | Sell |
| 200-day SMA: | 8.14 | Buy |
| 8-day EMA: | 9.09 | Buy |
| 20-day EMA: | 8 | Buy |
| 50-day EMA: | 5.23 | Buy |
| 200-day EMA: | 1.76 | Buy |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.78 | Buy |
| 20-day SMA: | 53.22 | Buy |
| 50-day SMA: | 44.33 | Buy |
| 200-day SMA: | 24.55 | Buy |
| 8-day EMA: | 65.16 | Buy |
| 20-day EMA: | 56.66 | Buy |
| 50-day EMA: | 46.43 | Buy |
| 200-day EMA: | 30.4 | Buy |
VNET Group, Inc. Earnings Growth & VNET Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $0.20 per share.
Arrowhead Pharmaceuticals, Inc. Earnings Growth & ARWR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.49 per share, and a decrease next year of $3.13 per share.
VNET Group, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arrowhead Pharmaceuticals, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||